南财智讯12月24日电，步长制药公告，公司控股子公司步长众鑫康医药拟与湖北合俊腾辉贸易有限公司 共同出资设立新公司，其中步长众鑫康医药以自有资金出资180.00万元，持股比例60%；湖北合俊腾辉 贸易有限公司出资120.00万元，持股比例40%。新设公司注册资本为300.00万元，注册地址为湖北省武 汉市蔡甸区，经营范围包括医疗器械互联网信息服务、食品互联网销售等，目前已完成工商登记注册的 前期准备工作。本次投资旨在拓展公司在互联网医疗及健康产品领域的业务布局，增强市场竞争力。本 次交易不构成关联交易，亦不构成重大资产重组，无需提交上市公司股东会审议。公司预计本次投资对 公司本年度财务状况无重大影响，但对未来持续经营能力和综合竞争力具有积极作用。 ...

Core Insights - PepsiCo reported third-quarter earnings that exceeded Wall Street expectations, with revenue of $23.94 billion and adjusted earnings per share of $2.29, surpassing forecasts of $23.85 billion and $2.27 respectively [1] - The North American beverage segment showed a 2% growth, marking the highest growth rate in nearly two years, which offset the ongoing slowdown in the food business [1] - The acquisition of the health soda brand Poppi contributed significantly to growth, with retail sales increasing over 50% year-over-year [1] Financial Performance - Total revenue for the quarter reached $23.94 billion, slightly above the expected $23.85 billion [1] - Adjusted earnings per share were reported at $2.29, exceeding the market expectation of $2.27 [1] - The North American beverage business achieved a 2% growth, counterbalancing a 3% decline in food sales [1][2] Regional Performance - The EMEA region experienced a revenue growth of 5.5%, while Latin America saw a 4% increase, helping to mitigate the weakness in North American food sales [2] - The company anticipates low single-digit organic revenue growth for 2025, with core constant currency earnings expected to remain flat compared to the previous year [2] Management Changes - PepsiCo announced a management change, with CFO Jamie Caulfield set to retire and Steve Schmitt appointed as the new CFO effective November 10 [2] - Darren Walker will also retire from the board, with the change effective November 19 [2] Strategic Focus - The company is expanding its portfolio to include healthier, high-protein, and portion-controlled products in response to changing consumer preferences [2] - PepsiCo is facing pressures from economic uncertainties and health policy impacts [2] Investor Pressure - Elliott Investment Management holds approximately $4 billion in PepsiCo shares and is urging the company to evaluate and streamline its snack product portfolio [3]